Search is Powered by Google
HIV / AIDS News

Needle-Exchange Pilot Programs Launch In New Jersey

Main Category: HIV / AIDS
Also Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 03 Jan 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

The Philadelphia Inquirer last week examined the launch of pilot needle-exchange programs in New Jersey that aim to prevent the spread of HIV/AIDS among injection drug users. The pilot program has been in effect in Atlantic City since Nov. 27. A program in Camden is scheduled to launch this month, and programs in Newark and Paterson will start this winter, Roseanne Scotti, director of the Drug Policy Alliance of New Jersey, said (Urgo, Philadelphia Inquirer, 12/24/07).

The New Jersey Department of Health and Senior Services in August approved the establishment of three-year needle-exchange programs in the four cities. Gov. Jon Corzine (D) in December 2006 signed into law a bill that allows six cities to establish needle-exchange programs and provides $10 million to drug treatment programs in the state. The state health commissioner must report to the governor and state Legislature on whether the needle-exchange programs are effective. In addition, people who participate in and run the programs are required to carry identification cards that protect them from being arrested for possessing drug paraphernalia. No state funding will be allocated to the cities for operating needle-exchange programs.

To be eligible for the program, a city must have at least 300 HIV/AIDS cases attributed to injection drug use per 100,000 residents and at least 350 confirmed HIV/AIDS cases overall. Each program will be required to report data on the number of people participating in the programs and referred to drug treatment, the status of their treatment and the number of syringes exchanged. According to state Health Commissioner Fred Jacobs, the data will be used to promote the expansion of the programs and will remain anonymous (Kaiser Daily HIV/AIDS Report, 8/2/07).

According to the Inquirer, New Jersey is the last state to implement needle-exchange programs. Supporters of the pilot programs note that about 45% of New Jersey's new reported HIV cases involve infection due to injection drug use using contaminated needles. Some opponents of the programs have said needle exchanges appear to condone or promote injection drug use, the Inquirer reports.

The Atlantic City program is administered by Health and Human Services for Atlantic City and operates out of the South Jersey AIDS Alliance's Oasis Center. Georgett Watson, program director of the alliance, said that in the first few weeks the program provided 90 clients with 11 clean needles for every used needle clients returned. Two of the clients who came in to exchange needles have entered treatment programs, Watson said (Philadelphia Inquirer, 12/24/07).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA To Recommend That Doctors Conduct Genetic Screening Before Prescribing Antiretroviral Abacavir To Reduce Allergic Reactions
25 Jul 2008
FDA on Thursday is expected to issue an advisory that urges physicians to conduct genetic testing before prescribing GlaxoSmithKline's antiretroviral drug abacavir to reduce allergic reactions in people taking the drug, the...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Keeping a Personal Medical Record image Keeping a Personal Medical Record

Medical information is usually scattered in many different places. To receive the best possible health care, people are encouraged to gather information in one place and create a personal medical record...

View more videos...